Bionutrics changes names to Synovics Pharmaceuticals, modifies trading symbol

By Jennifer Chiou

New York, April 11 - Bionutrics, Inc. announced it changed its name to Synovics Pharmaceuticals, Inc. and altered its trading symbol to "SYVC" on the OTC Bulletin Board.

"With rights to technology for a pipeline of twenty 505(b)(2) and generic drug formulations, and the intended acquisition of Kirk Pharmaceuticals, we believe we have good cause to be very excited about the prospects of our future," chairman and chief executive officer Ronald H. Lane said in a news release.

The company previously said it filed a preliminary 14C with the Securities and Exchange Commission on Feb. 3 to begin the name-changing process.

Based in Phoenix, Synovics is a specialty pharmaceutical company. It has two generic drug candidates, SNG1001a and SNG1002a, which use oral release-controlled delivery technology.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.